Hultberg Björn
Institute of Laboratory Medicine, Department of Clinical Chemistry, University Hospital, S-22185 Lund, Sweden.
Clin Chim Acta. 2005 Jun;356(1-2):117-24. doi: 10.1016/j.cccn.2005.01.014.
Many clinical and epidemiological studies show that mild hyperhomocysteinemia is associated with premature vascular disease. Information about the metabolism of homocysteine is therefore essential for an understanding of its role in atherogenesis, thereby enabling a modulation of that risk.
In the present study factors influencing the elimination of exogenously added homocysteine in HeLa and hepatoma cell cultures have been investigated with and without inhibition of the transmethylation pathway by adenosine-dialdehyde.
Agents with antioxidative effect (copper chelator and thiols) increased the metabolic removal of extracellular homocysteine in HeLa cell cultures, whereas in hepatoma cell cultures only the thiol N-acetylcysteine increased the elimination. The oxidative agent (copper ions) and cyst(e)ine transport inhibitors decreased the removal in both HeLa and hepatoma cell cultures. The inhibition of the transmethylation pathway by adenosine-dialdehyde increased the removal of exogenously added homocysteine and the addition of the different redox agents and cyst(e)ine transport inhibitors did not specifically influence this increase.
The elevated removal of exogenously added homocysteine in the presence of adenosine-dialdehyde might be attributed to limited availability of intracellular homocysteine, which leads to a larger amount of extracellular homocysteine being internalized.
许多临床和流行病学研究表明,轻度高同型半胱氨酸血症与血管疾病早发有关。因此,有关同型半胱氨酸代谢的信息对于理解其在动脉粥样硬化形成中的作用至关重要,从而能够对该风险进行调控。
在本研究中,在有和没有用腺苷二醛抑制转甲基途径的情况下,研究了影响HeLa细胞和肝癌细胞培养物中外源性添加的同型半胱氨酸清除的因素。
具有抗氧化作用的试剂(铜螯合剂和硫醇)增加了HeLa细胞培养物中细胞外同型半胱氨酸的代谢清除,而在肝癌细胞培养物中,只有硫醇N-乙酰半胱氨酸增加了清除。氧化剂(铜离子)和胱氨酸转运抑制剂降低了HeLa细胞和肝癌细胞培养物中的清除。腺苷二醛对转甲基途径的抑制增加了外源性添加的同型半胱氨酸的清除,并且添加不同的氧化还原试剂和胱氨酸转运抑制剂并没有特异性地影响这种增加。
在腺苷二醛存在的情况下,外源性添加的同型半胱氨酸清除增加可能归因于细胞内同型半胱氨酸的可用性有限,这导致更多的细胞外同型半胱氨酸被内化。